This study aims to tackle the intricate challenge of predicting RNA-small molecule binding sites to explore the potential value in the field of RNA drug targets. To address this challenge, we propose the MultiModRLBP method, which integrates multi-modal features using deep learning algorithms. These features include 3D structural properties at the nucleotide base level of the RNA molecule, relational graphs based on overall RNA structure, and rich RNA semantic information. In our investigation, we gathered 851 interactions between RNA and small molecule ligand from the RNAglib dataset and RLBind training set. Unlike conventional training sets, this collection broadened its scope by including RNA complexes that have the same RNA sequence but change their respective binding sites due to structural differences or the presence of different ligands. This enhancement enables the MultiModRLBP model to more accurately capture subtle changes at the structural level, ultimately improving its ability to discern nuances among similar RNA conformations. Furthermore, we evaluated MultiModRLBP on two classic test sets, Test18 and Test3, highlighting its performance disparities on small molecules based on metal and non-metal ions. Additionally, we conducted a structural sensitivity analysis on specific complex categories, considering RNA instances with varying degrees of structural changes and whether they share the same ligands. The research results indicate that MultiModRLBP outperforms the current state-of-the-art methods on multiple classic test sets, particularly excelling in predicting binding sites for non-metal ions and instances where the binding sites are widely distributed along the sequence. MultiModRLBP also can be used as a potential tool when the RNA structure is perturbed or the RNA experimental tertiary structure is not available. Most importantly, MultiModRLBP exhibits the capability to distinguish binding characteristics of RNA that are structurally diverse yet exhibit sequence similarity. These advancements hold promise in reducing the costs associated with the development of RNA-targeted drugs.

Effectively and accurately predicting the effects of interactions between proteins after amino acid mutations is a key issue for understanding the mechanism of protein function and drug design. In this study, we present a deep graph convolution (DGC) network-based framework, DGCddG, to predict the changes of protein-protein binding affinity after mutation. DGCddG incorporates multi-layer graph convolution to extract a deep, contextualized representation for each residue of the protein complex structure. The mined channels of the mutation sites by DGC is then fitted to the binding affinity with a multi-layer perceptron. Experiments with results on multiple datasets show that our model can achieve relatively good performance for both single and multi-point mutations. For blind tests on datasets related to angiotensin-converting enzyme 2 binding with the SARS-CoV-2 virus, our predicted results are consistent with some biological insights to explain the higher infectiousness of Sars-CoV-2. Code and data availability: https://github.com/lennylv/DGCddG.

Protein-ligand interactions are crucial for understanding various biological processes and drug discovery and design. However, experimental methods are costly; single-ligand-oriented methods are tailored to specific ligands; multi-ligand-oriented methods are constrained by the lack of ligand encoding. In this study, we propose a structure-based method called LABind, designed to predict binding sites for small molecules and ions in a ligand-aware manner. LABind utilizes a graph transformer to capture binding patterns within the local spatial context of proteins, and incorporates a cross-attention mechanism to learn the distinct binding characteristics between proteins and ligands. Experimental results on three benchmark datasets demonstrate both the effectiveness of LABind and its ability to generalize to unseen ligands. Further analysis validates that LABind can effectively integrate ligand information to predict binding sites. Additionally, the application of LABind is extended to binding site center localization, sequence-based methods, and molecular docking tasks.

Nucleosome positioning is involved in diverse cellular biological processes by regulating the accessibility of DNA sequences to DNA-binding proteins and plays a vital role. Previous studies have manifested that the intrinsic preference of nucleosomes for DNA sequences may play a dominant role in nucleosome positioning. As a consequence, it is nontrivial to develop computational methods only based on DNA sequence information to accurately identify nucleosome positioning, and thus intend to verify the contribution of DNA sequences responsible for nucleosome positioning. In this work, we propose a new deep learning-based method, named DeepNup, which enables us to improve the prediction of nucleosome positioning only from DNA sequences. Specifically, we first use a hybrid feature encoding scheme that combines One-hot encoding and Trinucleotide composition encoding to encode raw DNA sequences; afterwards, we employ multiscale convolutional neural network modules that consist of two parallel convolution kernels with different sizes and gated recurrent units to effectively learn the local and global correlation feature representations; lastly, we use a fully connected layer and a sigmoid unit serving as a classifier to integrate these learned high-order feature representations and generate the final prediction outcomes. By comparing the experimental evaluation metrics on two benchmark nucleosome positioning datasets, DeepNup achieves a better performance for nucleosome positioning prediction than that of several state-of-the-art methods. These results demonstrate that DeepNup is a powerful deep learning-based tool that enables one to accurately identify potential nucleosome sequences.